CoChat

ERβ-dependent effects on uterine endothelial cells are cell specific and mediated via Sp1

Open access
Greaves, Erin, Collins, Frances, Critchley, Hilary O.D., Saunders, Philippa T.K. · 2013 · Human Reproduction
Cited by 28

The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.

Abstract

STUDY QUESTION: What are the in vitro effects of estrogen receptor β (ERβ) activation on the function of endothelial cells (ECs) from different vascular beds: human endometrial ECs (HEECs; endometrium), uterine myometrial microvascular ECs (UtMVECs; myometrium) and human umbilical vein ECs (HUVECs)? SUMMARY ANSWER: Studies conducted in vitro demonstrate that the ERβ agonist 2,3-bis(4-hydroxy-phenyl)-propionitrile (DPN) has EC type-specific effects on patterns of gene expression and network formation. Identification of a key role for the transcription factor Sp1 in ERβ-dependent signaling in uterine ECs offers new insights into cell-specific molecular mechanisms of estrogen action in the human uterus. WHAT IS KNOWN ALREADY: Estrogens, acting via ERs (ERα and ERβ), have important, body-wide impacts on the vasculature. The human uterus is an estrogen target organ, the endometrial lining of which exhibits physiological, cyclical angiogenesis. In fixed tissue sections, human endometrial ECs are immunopositive for ERβ. STUDY DESIGN, SIZE, DURATION: Cells were treated with a vehicle control or the ERβ agonist, DPN, for 2 h or 24 h (n = 5) followed by gene expression analysis. Functional assays were analyzed after a 16 h incubation with ligand (n = 5). PARTICIPANT/MATERIALS, SETTING, METHODS: Analysis of DPN-treated ECs using Taqman gene array cards focused on genes involved in angiogenesis and inflammation identified cell type-specific ERβ-dependent changes in gene expression, with validation using qPCR and immunohistochemistry. Molecular mechanisms involved in ERβ signaling were investigated using bioinformatics, reporter assays, immunoprecipitation, siRNA and a specific inhibitor blocking Sp1-binding sites. The endometrium and myometrium from women with regular menses were used to validate the protein expression of candidate genes. MAIN RESULTS AND THE ROLE OF CHANCE: HEECs and UtMVECs were ERβ+/ERα-. Treatment of ECs with DPN had opposite effects on network formation: a decrease in network formation in HEECs (P ≤ 0.001) but an increase in UtMVECs (P ≤ 0.05). Genomic analysis identified opposite changes in ERβ target gene expression with only three common transcripts (HEY1, ICAM1, CASP1) in all three ECs; a unique profile was observed for each. An important role for Sp1 was identified, consistent with the regulation of ERβ target genes via association with the transcription factor ('tethered' mechanism). LIMITATIONS, REASONS FOR CAUTION: The study was mainly carried out in vitro using ECs of which one type was immortalized. Although the analysis of the protein expression of candidate genes was carried out using intact tissue samples from patients, investigations into in vivo angiogenesis were not carried out. WIDER IMPLICATIONS OF THE FINDINGS: These results have implications for our understanding of the mechanisms responsible for ERβ-dependent changes in EC gene expression in hormone-dependent disorders.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/humrep/det235

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 39

  1. Albrecht, 2003, Effect of estrogen on angiogenesis in co-cultures of human endometrial cells and microvascular endothelial cells, Hum Reprod, 18, 2039, 10.1093/humrep/deg415 · DOI
  2. Bao, 2009, The role of vascular endothelial growth factor in wound healing, J Surg Res, 153, 347, 10.1016/j.jss.2008.04.023 · DOI · Paper page
  3. Cho, 1998, Effects of estrogen on tight junctional resistance in cultured human umbilical vein endothelial cells, J Soc Gynecol Investig, 5, 260, 10.1016/S1071-5576(98)00025-2 · doi:10.1016/s1071-5576(98)00025-2
  4. Farhat, 1996, The vascular protective effects of estrogen, FASEB J, 10, 615, 10.1096/fasebj.10.5.8621060 · DOI · Paper page
  5. Girling, 2005, Recent advances in endometrial angiogenesis research, Angiogenesis, 8, 89, 10.1007/s10456-005-9006-9 · DOI · Paper page
  6. Gustafsson, 2003, What pharmacologists can learn from recent advances in estrogen signalling, Trends Pharmacol Sci, 24, 479, 10.1016/S0165-6147(03)00229-3 · DOI · Paper page
  7. Hermenegildo, 2000, Pure anti-oestrogens, Hum Reprod Update, 6, 237, 10.1093/humupd/6.3.237 · DOI
  8. Hewitt, 2005, Lessons in estrogen biology from knockout and transgenic animals, Annu Rev Physiol, 67, 285, 10.1146/annurev.physiol.67.040403.115914 · DOI · Paper page
  9. Jabbour, 2009, Inflammatory pathways in female reproductive health and disease, Reproduction, 138, 903, 10.1530/REP-09-0247 · DOI · Paper page
  10. Jensen, 1998, Human umbilical vein endothelial cells lack expression of the estrogen receptor, Endothelium, 6, 9, 10.3109/10623329809053401 · doi:10.3109/10623329809053401
  11. Kayisli, 2004, Regulation of angiogenic activity of human endometrial endothelial cells in culture by ovarian steroids, J Clin Endocrinol Metab, 89, 5794, 10.1210/jc.2003-030820 · DOI
  12. Krikun, 2005, Metalloproteinase expression by control and telomerase immortalized human endometrial endothelial cells, Histol Histopathol, 20, 719
  13. Krikun, 2005, Endometrial endothelial cell steroid receptor expression and steroid effects on gene expression, J Clin Endocrinol Metab, 90, 1812, 10.1210/jc.2004-1814 · DOI
  14. Leitman, 2010, Regulation of specific target genes and biological responses by estrogen receptor subtype agonists, Curr Opin Pharmacol, 10, 629, 10.1016/j.coph.2010.09.009 · DOI
  15. Martin, 2007, Differential cell-specific modulation of HOXA10 by estrogen and specificity protein 1 response elements, J Clin Endocrinol Metab, 92, 1920, 10.1210/jc.2006-1694 · DOI
  16. Matthews, 2003, Estrogen signaling: a subtle balance between ER alpha and ER beta, Mol Interv, 3, 281, 10.1124/mi.3.5.281 · DOI · Paper page
  17. McCrohon, 2000, A comparison of endothelial function in Caucasian and Chinese women before and after the menopause, Maturitas, 35, 31, 10.1016/S0378-5122(00)00102-X · DOI
  18. Meyers, 2001, Estrogen receptor-beta potency-selective ligands: structure-activity relationship studies of diarylpropionitriles and their acetylene and polar analogues, J Med Chem, 44, 4230, 10.1021/jm010254a · DOI · Paper page
  19. Monroe, 2003, Estrogen receptor isoform-specific regulation of endogenous gene expression in human osteoblastic cell lines expressing either ERalpha or ERbeta, J Cell Biochem, 90, 315, 10.1002/jcb.10633 · DOI · Paper page
  20. Muyan, 2012, The ligand-mediated nuclear mobility and interaction with estrogen-responsive elements of estrogen receptors are subtype specific, J Mol Endocrinol, 49, 249, 10.1530/JME-12-0097 · DOI
  21. Nayak, 2002, Vascular proliferation and vascular endothelial growth factor expression in the rhesus macaque endometrium, J Clin Endocrinol Metab, 87, 1845, 10.1210/jcem.87.4.8413 · DOI
  22. Niklaus, 2003, Effect of estrogen on vascular endothelial growth/permeability factor expression by glandular epithelial and stromal cells in the baboon endometrium, Biol Reprod, 68, 1997, 10.1095/biolreprod.102.011288 · DOI
  23. Nilsson, 2010, Estrogen receptors: therapies targeted to receptor subtypes, Clin Pharmacol Ther, 89, 44, 10.1038/clpt.2010.226 · DOI · Paper page
  24. Nilsson, 2001, Mechanisms of estrogen action, Physiol Rev, 81, 1535, 10.1152/physrev.2001.81.4.1535 · DOI · Paper page
  25. Nilsson, 2011, Development of subtype-selective oestrogen receptor-based therapeutics, Nat Rev Drug Discov, 10, 778, 10.1038/nrd3551 · DOI · Paper page
  26. O'Lone, 2004, Genomic targets of nuclear estrogen receptors, Mol Endocrinol, 18, 1859, 10.1210/me.2003-0044 · DOI · Paper page
  27. Paruthiyil, 2009, Drug and cell type-specific regulation of genes with different classes of estrogen receptor beta-selective agonists, PLoS One, 4, e6271, 10.1371/journal.pone.0006271 · DOI
  28. Rocha, 2009, Molecular differentiation and specialization of vascular beds, Angiogenesis, 12, 139, 10.1007/s10456-009-9132-x · DOI · Paper page
  29. Schatz, 2000, Human endometrial endothelial cells: isolation, characterization, and inflammatory-mediated expression of tissue factor and type 1 plasminogen activator inhibitor, Biol Reprod, 62, 691, 10.1095/biolreprod62.3.691 · DOI · Paper page
  30. Smith, 2001, Angiogenesis and reproduction, BJOG, 108, 777
  31. Su, 2011, Estrogen receptor-β and fetoplacental endothelial prostanoid biosynthesis: a link to clinically demonstrated fetal growth restriction, J Clin Endocrinol Metab, 96, E1558, 10.1210/jc.2011-1084 · DOI
  32. Sun, 2003, Molecular basis for the subtype discrimination of the estrogen receptor-beta-selective ligand, diarylpropionitrile, Mol Endocrinol, 17, 247, 10.1210/me.2002-0341 · DOI · Paper page
  33. Sunkara, 2010, The effect of intramural fibroids without uterine cavity involvement on the outcome of IVF treatment: a systematic review and meta-analysis, Hum Reprod, 25, 418, 10.1093/humrep/dep396 · DOI · Paper page
  34. Vitale, 2010, Gender differences in the cardiovascular effects of sex hormones, Fundam Clin Pharmacol, 24, 675, 10.1111/j.1472-8206.2010.00817.x · DOI
  35. Vivar, 2010, Estrogen receptor beta binds to and regulates three distinct classes of target genes, J Biol Chem, 285, 22059, 10.1074/jbc.M110.114116 · DOI
  36. Weis, 2011, Tumor angiogenesis: molecular pathways and therapeutic targets, Nat Med, 17, 1359, 10.1038/nm.2537 · DOI · Paper page
  37. Yang, 2011, Estrogen, hormonal replacement therapy and cardiovascular disease, Curr Opin Nephrol Hypertens, 20, 133, 10.1097/MNH.0b013e3283431921 · DOI · Paper page
  38. Zaitseva, 2004, Estrogen receptor-alpha agonists promote angiogenesis in human myometrial microvascular endothelial cells, J Soc Gynecol Investig, 11, 529, 10.1016/j.jsgi.2004.06.004 · DOI
  39. Zhao, 2009, Microarray analysis of altered gene expression in ERbeta-overexpressing HEK293 cells, Endocrine, 36, 224, 10.1007/s12020-009-9233-8 · DOI

Cited by

See all 28

Metadata

Authors
Greaves, E., Collins, F., Critchley, H. O. D., & Saunders, P. T. K.
Venue
Human Reproduction
Published
2013-06-11
Volume
28
Issue
9
Pages
2490-2501
ISSN
  • 0268-1161 (ISSN-L)
  • 1460-2350
OpenAlex
W2103012425
Cited by
28
References
7
FWCI
2.23
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.